Cargando…
Health economic analyses of the Global Programme to Eliminate Lymphatic Filariasis
The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was established by the WHO in 2000. It aims to eliminate lymphatic filariasis as a public health problem. This paper summarises the key estimates of the cost-effectiveness and economic benefits related to the mass drug administration (MD...
Autor principal: | Turner, Hugo C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753169/ https://www.ncbi.nlm.nih.gov/pubmed/33349885 http://dx.doi.org/10.1093/inthealth/ihaa095 |
Ejemplares similares
-
The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014)
por: Turner, Hugo C., et al.
Publicado: (2016) -
Caring for patients in the global programme to eliminate lymphatic filariasis
por: Mackenzie, Charles D, et al.
Publicado: (2020) -
The role of medicine donations in the global programme for the elimination of lymphatic filariasis
por: Williams, Tijana, et al.
Publicado: (2020) -
A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000–2020)
por: Turner, Hugo C., et al.
Publicado: (2022) -
Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success
por: Ichimori, Kazuyo, et al.
Publicado: (2014)